The expression status of CD133 is associated with the pattern and timing of primary glioblastoma recurrence.
Shibahara I, Sonoda Y, Saito R, Kanamori M, Yamashita Y, Kumabe T, Watanabe M, Suzuki H, Watanabe T, Ishioka C, Tominaga T.
Shibahara I, et al. Among authors: watanabe t, watanabe m.
Neuro Oncol. 2013 Sep;15(9):1151-9. doi: 10.1093/neuonc/not066. Epub 2013 May 7.
Neuro Oncol. 2013.
PMID: 23658323
Free PMC article.